Friday, July 31, 2026

ATEEZ Teams Up with G-Eazy for Epic ‘Work’ Remix!

ATEEZ has teamed up with G-Eazy to release the fourth remix of their title track, "WORK," from their 10th mini album.

Russia Openly Violates UN Sanctions, Trading North Korean Labor in Defiance of US

A Russian agency advertises supplying 2,000 North Korean female workers weekly, raising concerns over human rights violations.

Long-Term Study Finds North Korean Defector Youth Face 30% Higher Risk of Mental Disorders

North Korean defector children face 1.3 times higher risk of mental disorders like PTSD and ADHD than South Korean peers, study finds.

Tag: development

North KoreaKoreaKimMilitaryAISouth KoreamarketrelationsInternational

Hyundai Motor Group Recruits Former Samsung Executive to Lead Autonomous Driving AI Development

Hyundai Motor Group appoints Kwon Jeong-hyun as head of Autonomous Driving Development, enhancing its autonomous mobility technologies.

Revolutionizing Material Development: How LG CNS and AI Are Slashing Time and Costs

LG CNS joins a global initiative with NVIDIA and Meta to enhance new material development using AI, cutting timelines significantly.

Pharos iBio Targets Global Licensing Deals, Expands U.S. and European Market Strategy

Pharos iBio aims to secure licensing deals and enhance its AI drug discovery platform for rare diseases, targeting global partnerships.

Lunit Joins Global AI Consortium for Next-Gen Drug Development: What This Means for Precision Medicine

Lunit joins an AI consortium to enhance drug development through AI-driven pathology and biomarker analysis, collaborating with global firms.

Breakthrough in MASH Treatment: How miRNA-10a Outperforms Resmetirom in Fat Reduction

RXBio's miRNA-10a shows superior efficacy over Resmetirom in treating MASH, reducing fat, fibrosis, and inflammation significantly.

Samsung Electronics Launches Dedicated Robotics Division Under CEO to Accelerate Robot Business

Samsung Electronics is launching the RX Business Promotion Office to boost its robotics sector and develop AI-driven autonomous factories.

Kangstem Biotech Signs Organoid Technology Evaluation Agreement With Global Top Five Pharmaceutical Company

Kangstem Biotech has signed an agreement with a top pharmaceutical company to evaluate drug candidates using its hair follicle organoid platform.

Humanoid Robots Will Be Driven by Data, Not Just AI Models, Omdia Says: South Korea Could Become Alternative to U.S.-China Supply Chain

Data collection and ecosystem development are crucial for the humanoid robot industry's success, with South Korea as a potential third supply chain.

Unlocking the Future: Diden Robotics and Movin’s Breakthrough in Humanoid AI Motion Capture

Diden Robotics and Movin collaborate to enhance humanoid robots with precise human motion data for improved industrial applications.

Penetrium: The Next Breakthrough in Cancer Immunotherapy Starting Phase 2 Trials in the U.S.

Penetrium BioScience launches a Phase 2 clinical trial for Penetrium, targeting tumor microenvironments to enhance cancer immunotherapy.

Shaperon Secures South Korean Patent for Pulmonary Fibrosis Drug Candidate NuPulin

Shaperon secures a South Korean patent for NuPulin, an oral drug for idiopathic pulmonary fibrosis, showing promising preclinical results.

Grok 4.5 vs GPT-5.6: Which AI Model Will Dominate the Coding Market in 2026?

SpaceX AI launches Grok 4.5, an advanced AI model for coding, amid competition with OpenAI's upcoming GPT-5.6.

Interview: Huons’ PanGen Bets on ‘Development-Focused CDMO’ Strategy Built on Biosimilar Experience

South Korea's PanGen CDMO emphasizes development expertise and tailored services, enhancing drug development support for clients.

ABL Bio to Launch Global Phase 3 Trial of ABL111 in December, Targeting First-Line Gastric Cancer Treatment

ABL Bio will begin global Phase 3 trials for its dual antibody gastric cancer treatment 'ABL111' this December after FDA discussions.

Top News

- Our Sponsors Ad -

Follow us

Cars

Tech

future

health

© Copyright by News1. All Rights Reserved.